| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Curcubitacin E |
|---|
| Description | Curcubitacin E is a potent actin depolymerization inhibitor. Shown to have a different mechanism of action compared to Jasplakinolide (Cat. No. 1689), binding to a different site. Binds specifically to filamentous actin (F-actin) forming a covalent bond at residue Cys257, stabilizing F-actin without affecting actin polymerization or nucleation. Does not bind to monomeric actin (G-actin). Acts as an immunomodulator with anti-inflammatory and anti-tumorigenic properties in a range of cancer cell lines, mediated by its action on the cellular cytoskeleton, on mitotic pathways as well as on cellular autophagy. MW: 556.7. Purity ≥98% by HPLC |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Cuc E; α-Elaterin; α-Elaterine; NSC106399; BRN2343323 |
|---|
| Gene, Accession, CAS # | CAS: 18444-66-1 |
|---|
| Catalog # | B1592-1 |
|---|
| Price | |
|---|
| Order / More Info | Curcubitacin E from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|